Australia's Osteopore rises on signing exclusive deal for its orthopaedic products
** Shares of Osteopore OSX.AX up 2.6% to A$0.04, on track
for their best day since Oct. 25, if current trends hold
** The medical technology firm signs exclusive agreement
with Swiss holding co DiethelmKellerSiberHegner (DKSH)
** Agreement is to promote its off-the-shelf orthopaedic
products in Singapore, says co
** Stock has fallen ~67% YTD, as of last close
(Reporting by Sherin Sunny in Bengaluru)
((Sherin.Sunny@thomsonreuters.com))
Recent news on Osteopore
See all newsBrief: Osteopore Secures Market Access In Thailand For Full Range Of Orthopaedic Products
Brief: Osteopore Strikes Orthopaedic Deal For 5 Middle East Countries
Brief: Osteopore Achieves Market Access To Saudi Arabia For Craniofacial Products
Brief: Osteopore Launches Clinical Study For Paranasal Augmentation In Patients With Unilateral Cleft Lip
Australia's Osteopore advances on regulatory win in China's Hainan